Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adverse events and changes in disease activity across multiple treatment combinations using mirvetuximab soravtansine in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Mirvetuximab soravtansine (mirvetuximab soravtansine)

Snippet

Sponsor: AbbVie | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING